To outline the autoimmune involvement of heart and skeletal muscles and characterize the role of antistriational autoantibodies in myasthenia gravis.
Evaluation of autoimmune muscle targeting and antibody profiles in patients with myasthenia gravis.
Both heart and skeletal muscles serve as direct autoimmune targets in a subset of patients with myasthenia gravis.
Muscle autoimmunity manifests as a broad clinical spectrum associated with antistriational autoantibodies.
Abstract
Heart and skeletal muscles are autoimmune targets in some patients with MG. This autoimmunity has a broad clinical spectrum with antistriational autoantibodies.